Tumor Necrosis Factor α Blockade Exacerbates Murine Psoriasis-like Disease by Enhancing Th17 Function and Decreasing Expansion of Treg Cells
Tumor Necrosis Factor α Blockade Exacerbates Murine Psoriasis-like Disease by Enhancing Th17 Function and Decreasing Expansion of Treg Cells
复制标题
DOI:
10.1002/art.27203
复制
发表时间:
2010-02-01
影响因子:
--
通讯作者:
Young, Deborah A.
中科院分区:
文献类型:
--
作者:
Ma, Hak-Ling;Napierata, Lee;Young, Deborah A.
Objective. Patients with psoriasis and psoriatic arthritis respond well to tumor necrosis factor alpha (TNF alpha) blockers in general; however, there is now mounting evidence that a small cohort of patients with rheumatoid arthritis who receive TNF alpha blockers develop psoriasis. This study was undertaken to explore the mechanisms underlying TNF alpha blockade-induced exacerbation of skin inflammation in murine psoriasis-like skin disease.Methods. Skin inflammation was induced in BALB/c scid/scid mice after they received CD4+ CD45RB(high)CD25- (naive CD4) T cells from donor mice. These mice were treated with either anti interleukin- 12 (anti-IL-12)/23p40 antibody or murine TNFRII-Fc fusion protein and were examined for signs of disease, including histologic features, various cytokine levels in the serum, and cytokine or FoxP3 transcripts in the affected skin and draining lymph node (LN) cells. In a separate study, naive CD4+ T cells were differentiated into Th1 or Th17 lineages with antiCD3/ 28 magnetic beads and appropriate cytokines in the presence or absence of TNF alpha. Cytokine gene expression from these differentiated cells was also determined.Results. Neutralization of TNF alpha exacerbated skin inflammation and markedly enhanced the expression of the proinflammatory cytokines IL-1 beta, IL-6, IL-17, IL-21, and IL-22 but suppressed FoxP3 expression in the skin and reduced the number of FoxP3-positive Treg cells in the draining LNs. TNF alpha also demonstrated a divergent role during priming and reactivation of naive T cells.Conclusion. These results reveal a novel immunoregulatory role of TNF alpha on Th17 and Treg cells in some individuals, which may account for the exacerbation of skin inflammation in some patients who receive anti-TNF treatments.